All news

At €26.26 a share, Lakefront Biotherapeutics (LKFT) repurchased 126,322 shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Lakefront Biotherapeutics NV repurchased 126,322 ordinary shares between October 5 and October 9, 2026, at an average price of €26.26 per share, totaling €3,317,407.94. This share repurchase was part of a program announced on June 9, 2026. As of October 9, 2026, Lakefront holds 1,877,353 of its own ordinary shares.

Read original source

LKFT company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.